Olaparib plus bevacizumab for maintenance treatment of advanced ovarian, fallopian tube or primary peritoneal cancer : Committee papers
Cited by National Institute for Health and Care Excellence (NICE) on
The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.